WallStreetZenWallStreetZen

NASDAQ: CPRX
Catalyst Pharmaceuticals Inc Stock Ownership - Who owns Catalyst Pharmaceuticals?

Insider buying vs selling

Have Catalyst Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Brian ElsberndChief ComplianceLegal Officer2024-03-2725,000$16.44
$411.00kSell
Donald A. DenkhausDirector2024-02-0540,000$4.01
$160.40kBuy
Patrick J. McEnanyDirector2024-01-02250,000$1.13
$282.50kBuy
David S. TierneyDirector2024-01-0210,000$1.13
$11.30kBuy
Charles B. OkeeffeDirector2024-01-0260,000$1.13
$67.80kBuy
Molly HarperDirector2023-12-154,000$14.43
$57.72kSell
Molly HarperDirector2023-12-1510,000$5.78
$57.80kBuy
Molly HarperDirector2023-12-1510,000$14.37
$143.70kSell
David S. TierneyDirector2023-12-1250,000$1.13
$56.50kBuy
David S. TierneyDirector2023-12-1250,000$13.33
$666.25kSell

1 of 4

CPRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CPRX insiders and whales buy or sell their stock.

CPRX Shareholders

What type of owners hold Catalyst Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc13.42%15,822,299$257.43MInstitution
Deerfield Management Company LP Series C7.54%8,888,901$144.62MInstitution
Vanguard Group Inc6.04%7,120,417$115.85MInstitution
State Street Corp5.76%6,787,332$110.43MInstitution
Biomarin Pharmaceutical Inc5.66%6,666,667$108.47MInsider
Patrick J. McEnany4.21%4,966,021$80.80MInsider
Hubert E. Md Huckel3.22%3,793,238$61.72MInsider
Dimensional Fund Advisors LP2.21%2,601,797$42.33MInstitution
Geode Capital Management LLC1.87%2,200,225$35.80MInstitution
Morgan Stanley1.66%1,961,539$31.91MInstitution

1 of 3

CPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CPRX71.64%16.33%Net BuyingNet Buying
HRMY61.02%38.98%Net BuyingNet Buying
JANX54.14%45.86%Net Buying
FUSN71.20%28.80%
GERN72.04%1.23%Net Buying

Catalyst Pharmaceuticals Stock Ownership FAQ

Who owns Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals (NASDAQ: CPRX) is owned by 71.64% institutional shareholders, 16.33% Catalyst Pharmaceuticals insiders, and 12.03% retail investors. Biomarin Pharmaceutical Inc is the largest individual Catalyst Pharmaceuticals shareholder, owning 6.67M shares representing 5.66% of the company. Biomarin Pharmaceutical Inc's Catalyst Pharmaceuticals shares are currently valued at $106.27M.

If you're new to stock investing, here's how to buy Catalyst Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.